# Long-term Observational Study of the Safety of Roflumilast

> **NCT03381573** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 135856 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** Roflumilast

## Key facts

- **NCT ID:** NCT03381573
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-15
- **Primary completion:** 2022-09-16
- **Final completion:** 2022-09-16
- **Target enrollment:** 135856 (ACTUAL)
- **Last updated:** 2023-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03381573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03381573, "Long-term Observational Study of the Safety of Roflumilast". Retrieved via AI Analytics 2026-09-10 from https://api.ai-analytics.org/clinical/NCT03381573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*